Isabela Batsu

Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study.

D. Gaudet, M. Banach, J. López-Sendón, 2020, European journal of preventive cardiology.

Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE

D. Gaudet, M. Banach, J. López-Sendón, 2021, Archives of medical science : AMS.

The SYDNEY Device Study: A Multicenter, Randomized, Open-Label Usability Study of a 2-mL Alirocumab Autoinjector Device.

A. Merino-Trigo, J. Frias, M. Koren, 2019, Clinical therapeutics.